| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,514 |
8,527 |
$670K |
| J0178 |
Injection, aflibercept, 1 mg |
776 |
449 |
$537K |
| 92134 |
|
16,496 |
14,186 |
$410K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
6,461 |
5,051 |
$385K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
190 |
148 |
$214K |
| J9035 |
Injection, bevacizumab, 10 mg |
3,823 |
2,900 |
$165K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
811 |
754 |
$101K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
262 |
178 |
$15K |
| 67228 |
|
14 |
12 |
$9K |
| 76512 |
|
30 |
24 |
$1K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
50 |
40 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
15 |
$1K |
| 1036F |
|
2,187 |
2,111 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
152 |
147 |
$0.00 |
| 4177F |
|
14 |
14 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
134 |
130 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,859 |
2,761 |
$0.00 |
| 5010F |
|
154 |
149 |
$0.00 |
| 2022F |
|
494 |
469 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
14 |
14 |
$0.00 |